Common markers of proliferation

Nature Reviews Cancer

Volumn 6, Issue 2, 2006, Pages 99-106

  Whitfield, Michael L ^a   George, Lacy K ^a   Grant, Gavin D ^a   Perou, Charles M ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLINE; HYDROXYUREA; NOCODAZOLE; THYMIDINE; TRANSCRIPTION FACTOR E2F1;

BINDING SITE; BREAST TUMOR; CANCER CELL; CANCER DIAGNOSIS; CANCER PATIENT; CELL CULTURE; CELL CYCLE REGULATION; CELL DIVISION; CELL FUNCTION; CELL LINE; CELL PROLIFERATION; DNA DAMAGE; DNA REPLICATION; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; HELA CELL; HUMAN; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUMOR; MARKER GENE; METASTASIS; MICROARRAY ANALYSIS; MITOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES CEREVISIAE; TUMOR CELL;

CELL CYCLE; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; NEOPLASMS; PROGNOSIS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 33644834789     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1802     Document Type: Review

References (68)

1. Dai, H. et al. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. Cancer Res. 65, 4059-4066 (2005).
2. Paik, S. et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351, 2817-2826 (2004). One of the first clinical assays based on gene expression levels.
3. Rosenwald, A. et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3, 185-197 (2003).
4. Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869-10874 (2001).
5. Ross, D. T. et al. Systematic variation in gene expression patterns in human cancer cell lines. Nature Genet. 24, 227-235 (2000).
6. Perou, C. M. et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl Acad. Sci. USA 96, 9212-9217 (1999). The first study to correlate a gene expression profile with proliferation (the KI67-labelling index) in normal and tumour tissues. It reported that the proliferation profile was conserved across cell lines and primary tumour types.
7. Rhodes, D. R. et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl Acad. Sci. USA 101, 9309-9314 (2004). This study showed the universality of the proliferation signature by showing that it is a common feature across more than 40 distinct tumour data sets, comparing low-grade tumours with high-grade tumours.
8. Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2000).
9. Rosenwald, A. et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346, 1937-1947 (2002).
10. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000). This study correlated tumour mitotic grade with the proliferation signature.
11. van't Veer, L. J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (2002).
12. Bhattacharjee, A. et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl Acad. Sci. USA 98, 13790-13795 (2001).
13. Garber, M. E. et al. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl Acad. Sci. USA 98, 13784-13789 (2001).
14. Welsh, J. B. et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc. Natl Acad. Sci. USA 98, 1176-1181 (2001).
15. Lapointe, J. et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl Acad. Sci. USA 101, 811-816 (2004).
16. LaTulippe, E. et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 62, 4499-4506 (2002).
17. Chen, X. et al. Gene expression patterns in human liver cancers. Mol. Biol. Cell 13, 1929-1939 (2002).
18. Hippo, Y. et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 62, 233-240 (2002).
19. Rickman, D. S. et al. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res. 61, 6885-6891 (2001).
20. Chung, C. H. et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5, 489-500 (2004).
21. Chung, C. H., Bernard, P. S. & Perou, C. M. Molecular portraits and the family tree of cancer. Nature Genet. 32 (Suppl.), 533-540 (2002).
22. Whitfield, M. L. et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 13, 1977-2000 (2002). A comprehensive study of the cell-cycle-regulated genes during the cell divison cycle in a human cancer cell line. This study was the first to show that cell-cycle-regulated gene sets overlap with proliferation signatures in tumour samples.
23. Ishida, S. et al. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol. Cell. Biol. 21, 4684-4699 (2001).
24. Laub, M. T., McAdams, H. H., Feldblyum, T., Fraser, C. M. & Shapiro, L. Global analysis of the genetic network controlling a bacterial cell cycle. Science 290, 2144-2148 (2000).
25. Spellman, P. T. et al. Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol. Biol. Cell 9, 3273-3297 (1998).
26. Cho, R. J. et al. Transcriptional regulation and function during the human cell cycle. Nature Genet. 27, 48-54 (2001).
27. Cho, R. J. et al. A genome-wide transcriptional analysis of the mitotic cell cycle. Mol. Cell 2, 65-73 (1998).
28. Rustici, G. et al. Periodic gene expression program of the fission yeast cell cycle. Nature Genet 36, 809-817 (2004).
29. Iyer, V. R. et al. The transcriptional program in the response of human fibroblasts to serum. Science 283, 83-87 (1999).
30. Oliva, A. et al. The cell cycle-regulated genes of Schizosaccharomyces pombe. PLoS Biol. 3, e225 (2005).
31. Peng, X. et al. Identification of cell cycle-regulated genes in fission yeast. Mol. Biol. Cell 16, 1026-1042 (2005).
32. Chang, H. Y. et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol. 2, e7 (2004).
33. Chang, H. Y. et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc. Natl Acad. Sci. USA 102, 3738-3743 (2005).
34. Bootsma, D., Budke, L. & Vos, O. Studies on synchronous division of tissue culture cells initiated by excess thymidine. Exp. Cell. Res. 33, 301-309 (1964).
35. Reichard, P. & Ehrenberg, A. Ribonucleotide reductase - a radical enzyme. Science 221, 514-519 (1983).
36. Huberman, J. A. New views of the biochemistry of eucaryotic DNA replication revealed by aphidicolin, an unusual inhibitor of DNA polymerase α. Cell 23, 647-648 (1981).
37. Zieve, G. W., Tumbull, D., Mullins, J. M. & McIntosh, J. R. Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Nocodazole accumulated mitotic cells. Exp. Cell. Res. 126, 397-405 (1980).
38. Eliassen, K. A., Baldwin, A., Sikorski, E. M. & Hurt, M. M. Role for a YY1 binding site in replication-dependent mouse histone gene expression. Mol. Cell. Biol. 18, 7106-7118 (1998).
39. Schneiderman, M. H., Dewey, W. C., Leeper, D. B. & Nagasawa, H. Use of the mitotic selection procedure for cell cycle analysis. Comparison between the X-ray and cycloheximide C2 markers. Exp. Cell. Res. 74, 430-438 (1972).
40. Grabske, R. J., Lake, S., Gledhill, B. L. & Meistrich, M. L. Centrifugal elutriation: separation of spermatogenic cells on the basis of sedimentation velocity. J. Cell. Physiol. 86, 177-189 (1975).
41. Cooper, S. Rejoinder: whole-culture synchronization cannot, and does not, synchronize cells. Trends Biotechnol. 22, 274-276 (2004).
42. Cooper, S. Is whole-culture synchronization biology's 'perpetual-motion machine'? Trends Biotechnol. 22, 266-269 (2004).
43. Spellman, P. T. & Sherlock, G. Final words: cell age and cell cycle are unlinked. Trends Biotechnol. 22, 277-278 (2004).
44. Spellman, P. T. & Sherlock, G. Reply: whole-culture synchronization -effective tools for cell cycle studies. Trends Biotechnol. 22, 270-273 (2004).
45. Shedden, K. & Cooper, S. Analysis of cell-cycle-specific gene expression in human cells as determined by microarrays and double-thymidine block synchronization. Proc. Natl Acad. Sci. USA 99, 4379-4384 (2002).
46. Crawford, D. F. & Piwnica-Worms, H. The G2 DNA damage checkpoint delays expression of genes encoding mitotic regulators. J. Biol. Chem. 276, 37166-37177 (2001).
47. Rabouille, C. & Jokitalo, E. Golgi apparatus partitioning during cell division. Mol. Membr. Biol. 20, 117-127 (2003).
48. Shorter, J. & Warren, G. Golgi architecture and inheritance. Annu. Rev. Cell Dev. Biol. 18, 379-420 (2002).
49. Boyle, E. I. et al. GO::TermFinder - open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics 20, 3710-3715 (2004).
50. Mootha, V. K. et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genet. 34, 267-273 (2003).
51. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
52. Gonzalez, M. A., Tachibana, K. E., Laskey, R. A. & Coleman, N. Control of DNA replication and its potential clinical exploitation. Nature Rev. Cancer 5, 135-141 (2005).
53. Gonzalez, M. A. et al. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J. Pathol. 204, 121-130 (2004).
54. Gonzalez, M. A. et al. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J. Clin. Oncol. 21, 4306-4313 (2003).
55. Chatrath, P. et al. Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions. Br. J. Cancer 89, 1048-1054 (2003).
56. Glinsky, C. V., Berezovska, O. & Glinskii, A. B. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. 115, 1503-1521 (2005).
57. Sorlie, T. et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl Acad. Sci. USA 100, 8418-8423 (2003).
58. Johnson, D. G. & Walker, C. L. Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39, 295-312 (1999).
59. Senderowicz, A. M. The cell cycle as a target for cancer therapy: basic and clinical findings with the small molecule inhibitors flavopiridol and UCN-01. Oncologist 7 (Suppl.), 12-19 (2002).
60. Futreal, P. A. et al. A census of human cancer genes. Nature Rev. Cancer 4, 177-183 (2004).
61. Beach, D., Durkacz, B. & Nurse, P. Functionally homologous cell cycle control genes in budding and fission yeast. Nature 300, 706-709 (1982).
62. Lee, M. G. & Nurse, P. Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature 327, 31-35 (1987).
63. Troyanskaya, O. G., Dolinski, K., Owen, A. B., Altman, R. B. & Botstein, D. A Bayesian framework for combining heterogeneous data sources for gene function prediction (in Saccharomyces cerevisiae). Proc. Natl Acad. Sci. USA 100, 8348-8353 (2003).
64. Allegra, C. J. & Grem, J. L. in Cancer: Priciples and Practice of Oncology (eds. DeVita, V. T., Hellman, S. & Rosenberg, S. A.) 432-452 (Lippincott-Raven, Philadelphia, 1997).
65. Hurley, L. H. DNA and its associated processes as targets for cancer therapy. Nature Rev. Cancer 2, 188-200 (2002).
66. Stewart, C. F. & Ratain, M. J. in Cancer: Principles and Practice in Oncology (eds. DeVita, V. T., Hellman, S. & Rosenberg, S. A.) 452-467 (Lippincott-Raven, Philadelphia, 1997).
67. O'Dwyer, P. J., Johnson, S. W. & Hamilton, T. C. in Cancer Principles and Practices of Oncology (eds. DeVita, V. T., Hellman, S. & Rosenberg, S. A.) 418-432 (Lippincott-Raven, Philadelphia, 1997).
68. Segal, E., Friedman, N., Koller, D. & Regev, A. A module map showing conditional activity of expression modules in cancer. Nature Genet. 36, 1090-1098 (2004).